Professional Documents
Culture Documents
ISHAQ ARSHAD
BIOAVAILABILITY (BA)
Bioavailability is defined as
“Fraction of unchanged drug reaching systemic circulation
following administration by any route.”
By IV route, BA is 100% .
When the drug is given orally, only part of the administered dose
appears in the plasma.
I/V ROUTE:
100% BA
ORAL ROUTE:
BA is affected by different factors.
1-First pass hepatic metabolism
2-Solubility of drugs
3- Chemical instability
4-Nature of the drug formulation
FACTORS AFFECTING BA
1-First pass effect
Drug is absorbed from GIT, enters portal circulation before entering
into systemic circulation and metabolized in liver or gut wall, the
amount of unchanged drug entering systemic circulation is ↓.
This is called first-pass effect
90% of Nitroglycerin is cleared by first-pass effect so it is given S/L or
Transdermal
High dose of drug is required with high first pass effect.
FACTORS AFFECTING BA
2-Solubility of drugs
I/V:
Absorption not required and drug immediately leaves circulation and
enters tissues.
B- Brain is smaller and small amount of drug into it will raise the
tissue concentration.
FACTORS AFFECTING DISTRIBUTION OF DRUGS
4-Binding of drug to proteins
A-Binding to plasma proteins
Reversible binding to plasma proteins(albumin) slows the transfer of
drugs from vascular compartment
Concentration of free drug decreases due to elimination and protein
bound drug acts as reservoir.
B- Binding to tissue proteins
It leads to accumulation of drug in tissues (reservoir), prolonging the
duration of action and increasing the local toxicity e.g Chloroquine
binds to tissue proteins of various organs.
FACTORS AFFECTING DISTRIBUTION OF DRUGS
5-Lipophilicity
The chemical nature of the drug strongly influences its ability to
cross cell membranes.